Chapter 36: Actions of acetylcholine in the cerebral cortex and thalamus and implications for function
Year: 1993
Type: book-chapter
Abstract: The concerted investigation of cholinergic systems by a large number of scientists has yielded an unparalleled wealth of information from molecular sequencing of the nicotinic receptor-channel to the firing patterns of cholinergic neurons in behaving primates. Acetylcholine (ACh) can activate a wide variety of pre- and post-synaptic responses ranging from rapid excitation to prolonged inhibition on the ionic level to stimulation of phospholipid turnover or inhibition of adenylyl cyclase in the biochemical realm. This versatility of cholinergic neurons contributes to their involvement in a variety of normal and abnormal neuronal functions, such as those underlying learning and memory, arousal and attentiveness, sleep and Alzheimer's disease. Of the variety of cholinergic pathways present in the mammalian CNS, the ascending projections from the brainstem to the thalamus and from the basal forebrain to the cerebral cortex appear to be particularly important in the modulatory control of forebrain activity. The cholinergic receptors that have been implicated in this ascending modulation of forebrain activity are both of the muscarinic and nicotinic type, with prolonged changes in activity generally associated with muscarinic receptors and more phasic responses associated with nicotinic receptors. Pharmacologically, nicotinic receptors have traditionally been categorized into two main groups: neural (or ganglionic) and muscular. The nicotinic receptor-channel is a pentameric structure composed of, in order of mobility on SDS polyacrylamide gels, two α, one β, one γ (expressed in development; replaced by ɛ in adults) and one δ subunit surrounding a water-filled pore. Amino acid sequencing of subunits, which contain the binding site for receptor activation, revealed the presence of at least four distinct subtypes, termed α1x-4. These four different α subunits (αl, muscle; α2-4 neural) differ not only in their primary structure, but also in their pharmacological properties and their distribution in the CNS.
Source: Progress in brain research
Parent work: Cholinergic Function and Dysfunction
Author: David A. McCormick
Institution: Yale University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W937721687
